EUVIMEDEUVIMED entdecken
Crossref

Transcriptomic profiling of vitiligo patients shows polar immune dysregulation in involved and uninvolved skin

Patrick M Brunner, Eden David, Ester Del Duca, Meredith Manson, Agata Kurowski, Malini P Naidu, Lauren R Port, Jesus Gay-Mimbrera, Pedro J Gómez-Arias, Natalia Alkon, Jessica Beaziz-Tordjman, Yeriel Estrada und 3 weitere

Journal of Allergy and Clinical Immunology · 2025-10 · 156 (4) · 993-1007

DOI: 10.1016/j.jaci.2025.06.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2025-10. Verfasst von Patrick M Brunner und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY. Hauptthemen laut MEDLINE: Vitiligo, Skin, Transcriptome. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 115 Literaturangaben. Gefördert von: American Skin Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Vitiligo is a chronic autoimmune skin depigmenting disorder, with a major impact on quality of life. Therapeutic options are still limited, with only one topical JAK inhibitor being approved by the US Food and Drug Administration. Although vitiligo is primarily regarded as a TH1/interferon-driven disease, emerging evidence suggests the involvement of additional immune axes, but their relevance to disease pathogenesis remains unclear. OBJECTIVE: We sought to obtain a global cutaneous transcriptomic profile of lesional and nonlesional vitiligo. METHODS: We performed bulk RNA sequencing combined with real-time PCR and immunohistochemistry of skin biopsy samples from 15 lesional and nonlesional vitiligo samples and compared them to 14 matched healthy controls. Results were corroborated by single-cell RNA sequencing. RESULTS: Robust inflammatory dysregulation was captured not only in lesional but also nonlesional vitiligo skin relative to healthy controls. Lesional samples demonstrated upregulation of TH1 (OASL, CXCL9, CXCL10), TH2 (IL4, IL4R, CCL13, CCL17, CCL22, CCL26), and TH17/22 (IL20, S100A7, S100A8, S100A9, PI3) related markers. Similarly, nonlesional samples demonstrated activation of TH1 (CXCL9, OASL), TH2 (IL4R, IL10, CCL13, CCL17, CCL22), and TH17/22 (PI3, DEFB4A) associated markers. Clinical severity scores (Vitiligo Area Scoring Index and/or Vitiligo Disease Activity Index) significantly and positively correlated with multiple inflammatory mediators (ie, CXCL14, IL25, IL17RC) in lesional and/or nonlesional vitiligo skin. On a single-cell level, IL13 and IFNG expression were primarily found in nonlesional helper T cells and in lesional proliferating T cells, respectively. CONCLUSIONS: Our findings show that immune dysregulation in vitiligo involves immune axes beyond TH1/Tc1, with particular upregulation of type 2 markers already observed in nonlesional skin, suggesting a role during early lesion formation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VitiligoSkinTranscriptomeHumansFemaleMaleAdultGene Expression ProfilingMiddle AgedCytokinesTh1 CellsYoung AdultTh2 Cells

Stichwörter der Autor:innen

RNA sequencingT(H)2VitiligomelanogenesisscRNA-Seqskin biomarkers

Substanzen

Cytokines

Autor:innen und Institutionen

  • Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY; Dermatology Unit, Department of Clinical Internal, Anesthesiological and Cardiovascular Science, University of La Sapienza, Rome, Italy.
  • Inflammatory Immune-Mediated Chronic Skin Diseases Laboratory (GC26), Maimonides Biomedical Research Institute of Córdoba (IMIBIC), University of Córdoba, Reina Sofia University Hospital, Córdoba, Spain.
  • Inflammatory Immune-Mediated Chronic Skin Diseases Laboratory (GC26), Maimonides Biomedical Research Institute of Córdoba (IMIBIC), University of Córdoba, Reina Sofia University Hospital, Córdoba, Spain; Department of D…
  • Department of Dermatology, Medical University of Vienna, Vienna, Austria.
  • Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY; Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY; Pediatric Dermatology Unit, Schneider Children's Medi…

Förderung

  • American Skin Association

Zitieren

APA

Brunner, P. M., David, E., Del Duca, E., Manson, M., Kurowski, A., Naidu, M. P., Port, L. R., Gay-Mimbrera, J., Gómez-Arias, P. J., Alkon, N., Beaziz-Tordjman, J., Estrada, Y., Renert-Yuval, Y., Ruano, J., & Guttman-Yassky, E. (2025). Transcriptomic profiling of vitiligo patients shows polar immune dysregulation in involved and uninvolved skin. Journal of Allergy and Clinical Immunology, 156(4), 993-1007. https://doi.org/10.1016/j.jaci.2025.06.002

Vancouver

Brunner PM, David E, Del Duca E, Manson M, Kurowski A, Naidu MP, et al. Transcriptomic profiling of vitiligo patients shows polar immune dysregulation in involved and uninvolved skin. Journal of Allergy and Clinical Immunology. 2025;156(4):993-1007. doi:10.1016/j.jaci.2025.06.002

BibTeX
@article{Brunner2025,
  author = {Brunner, Patrick M and David, Eden and Del Duca, Ester and Manson, Meredith and Kurowski, Agata and Naidu, Malini P and Port, Lauren R and Gay-Mimbrera, Jesus and Gómez-Arias, Pedro J and Alkon, Natalia and Beaziz-Tordjman, Jessica and Estrada, Yeriel and Renert-Yuval, Yael and Ruano, Juan and Guttman-Yassky, Emma},
  title = {Transcriptomic profiling of vitiligo patients shows polar immune dysregulation in involved and uninvolved skin},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2025},
  volume = {156},
  number = {4},
  pages = {993--1007},
  doi = {10.1016/j.jaci.2025.06.002}
}
Kostenlos starten →